جست‌وجوی استاد و پژوهشگر

Suzaynn Schickمشاهده پروفایل

پژوهشگر

• Air Pollution
• Environmental Health
• Tobacco Smoke Toxicity
• +۴ مورد دیگر

Suzaynn Schick is a prominent researcher at the University of California San Francisco (UCSF), affiliated with the UCSF Center for Tobacco Control Research and Education, the Helen Diller Family Comprehensive Cancer Center, and the California Thirdhand Smoke Consortium. Her work focuses on the chemistry and toxicity of tobacco and cannabis smoke, with particular emphasis on thirdhand smoke as a long-term environmental pollutant. Education: B.S. in Cell and Molecular Biology (University of Washington, 1986-1989) Ph.D. in Biomedical Science (UCSF, 1991-2001) Postdoctoral studies in Public Health (UCSF, 2002-2006) and Inhalation Toxicology (UCSF, Feb 2006-Sept 2007) Schick's research explores how smoke pollutants contribute to cardiovascular and respiratory diseases. Her groundbreaking studies demonstrate that thirdhand smoke—a residue of oils and waxes on surfaces—remains carcinogenic long after active smoking ceases, challenging conventional assumptions about secondhand smoke risks. Recent publications highlight her work on thirdhand smoke's role in gastric tumor development, endothelial dysfunction from cannabis and cigarette aerosols, and the persistence of toxins in indoor environments. Her studies span molecular toxicology, air quality analysis, and public health policy implications. Scientific Awards: National Science Foundation Predoctoral Fellowship (1991) Schick's funded projects include investigations into melanin's role in thirdhand smoke absorption and environmental pollutant measurement. She advocates for stronger protections against involuntary smoke exposure through policy engagement and interdisciplinary collaboration.

• Microbiology
• Immunology
• Bacterial Pathogenesis
• +۷ مورد دیگر

Paul Brett is a Professor in the Department of Microbiology and Immunology at the University of Nevada, Reno School of Medicine. With over 25 years of experience researching Burkholderia pseudomallei , the causative agent of melioidosis, Dr. Brett leads a laboratory focused on understanding molecular mechanisms of bacterial pathogenesis and developing effective vaccines against this significant infectious disease. Dr. Brett received his B.Sc. in Biochemistry from the University of Victoria and his Ph.D. in Bacterial Pathogenesis from the University of Calgary. His academic credentials have supported a distinguished career investigating bacterial virulence mechanisms, particularly focusing on how B. pseudomallei evades host immune defenses through specialized surface structures. Dr. Brett's research program centers on elucidating how lipopolysaccharides and capsular polysaccharides expressed by B. pseudomallei contribute to immune evasion. His laboratory has developed significant expertise in carbohydrate purification/characterization, glycoconjugate synthesis, and comprehensive analysis of humoral/cellular immune responses. The ultimate goal of his research is to identify correlates of antigen-induced immunity against B. pseudomallei to develop safe, affordable, and effective melioidosis vaccines that could address this serious public health threat. Analysis of Dr. Brett's publication history reveals a consistent research trajectory with publications spanning from the early 2000s through 2025. His work demonstrates increasing sophistication in vaccine development approaches, with recent publications focusing on glycoconjugate vaccines, structural analysis of bacterial components, and innovative diagnostic methods for melioidosis. His research bridges molecular microbiology and translational immunology, with direct applications to vaccine design and development. Dr. Brett has participated in significant collaborative efforts, including the Melioidosis Diagnostic Workshop in 2013 and the Steering Group on Melioidosis Vaccine Development. These collaborations highlight his standing as a recognized expert in the field and his commitment to advancing international efforts to combat melioidosis. Though specific details about current students and grants are not provided in the available materials, Dr. Brett's active publication record through 2025 and his laboratory's described capabilities suggest he maintains a vibrant research program with ongoing funding and mentorship of graduate students and postdoctoral researchers. His work has direct relevance to both public health initiatives in melioidosis-endemic regions and biodefense preparedness efforts given B. pseudomallei 's classification as a Tier 1 select agent.

Giuseppe Faracoمشاهده پروفایل

استادیار

• Neurovascular Biology
• Cognitive Neuroscience
• Hypertension Effects on Brain
• +۷ مورد دیگر

Giuseppe Faraco is an Assistant Professor of Neuroscience at the Brain and Mind Research Institute, Weill Cornell Medical College. His research focuses on neurovascular dysfunction, cognitive impairment, and the interplay between hypertension, immune responses, and brain health. Education: Ph.D. and M.D. from University of Florence Faculty of Medicine and Surgery. Research interests center on neurovascular biology, dietary impacts on brain function, and immune-mediated cognitive decline. His work explores hypertension, tau phosphorylation, gut-brain axis, and blood-brain barrier dynamics in neurodegenerative diseases. Recent publications highlight mechanisms linking hypertension, inflammation, and cognitive dysfunction, with a focus on endothelial-immune crosstalk and dietary factors. Grants include funding from Cure Alzheimer’s Fund and National Institute of Neurological Disorders & Stroke to study hypertension, neurovascular dysregulation, and gut immunity.

Peter Murrayمشاهده پروفایل

استاد

• Immunology
• Macrophage biology
• Immune regulation
• +۴ مورد دیگر

Professor Dr. Peter Murray is a leading immunologist and permanent group leader of the "Immune Regulation" research group at the Max Planck Institute of Biochemistry in Martinsried, Germany. Since 2018, he has also served as an Honorary Professor at the Technical University of Munich (TUM). His research delves into the intricate mechanisms governing immune system decision-making, with a particular focus on macrophage biology, amino acid metabolism, and immunometabolism in health and disease. Education and Career: Ph.D., The Walter and Eliza Hall Institute of Medical Research, University of Melbourne (1988–1991) B.Sc. (Hons), Monash University, Melbourne (1984–1987) Post-Doctoral Fellow, Whitehead Institute & MIT (1991–1998) Assistant to Associate Member, St. Jude Children's Research Hospital (1998–2014) Group Leader (Permanent), Max Planck Institute of Biochemistry (2017–present) Honorary Professor, Technical University of Munich (2018–present) Research Interests: Professor Murray's work is centered on understanding how the immune system makes critical decisions, particularly how metabolic cues influence immune responses. His group investigates macrophage and T-cell interactions, amino acid metabolism in immune regulation, and the role of immunometabolism in diseases like cancer, autoimmunity, and chronic infections. The team employs innovative approaches, including spatial proteomics and iPSC-derived macrophage models, to uncover new biological principles and therapeutic targets. Scientific Awards and Honors: Elected to the American Academy of Microbiology (2015) St. Jude Children's Research Hospital Faculty Mentoring Award (2013) Elected Chair, American Society of Microbiology Division E (Immunology) (2012) The Hartwell Foundation Individual Biomedical Award (2010) C. J. Martin Fellow, NH&MRC Australia (1991–1994) Labs and Teams: Professor Murray leads the "Immune Regulation" research group at the Max Planck Institute of Biochemistry, a multidisciplinary team exploring the intersection of immunology and metabolism. The group collaborates extensively with international partners, including St. Jude Children's Research Hospital and various European research centers.

Maria M. Alemanمشاهده پروفایل

استادیار

• Blood and vascular biology
• Erythropoiesis
• Iron metabolism
• +۵ مورد دیگر

Maria M. Aleman, PhD is an Assistant Professor in the Department of Pharmacology at the University of North Carolina at Chapel Hill School of Medicine. Her research focuses on understanding fundamental mechanisms of erythropoiesis, blood and vascular biology, and the intersection of RNA regulation with iron metabolism in non-malignant hematology. Dr. Aleman's primary research interests center on erythropoiesis (red blood cell differentiation and maturation), investigating how hematopoietic stem cells differentiate through multiple stages until committing to the erythroid lineage. Her work particularly examines the family of dual functional proteins known as poly C binding proteins, which both regulate RNA processing and chaperone iron within cells. Using biochemical, cellular, and in vivo models, her laboratory explores the cross talk between iron trafficking and RNA regulation mediated by these proteins and how these activities are modulated by disease. Analysis of Dr. Aleman's publication record reveals a strong focus on hemostasis, thrombosis, and coagulation disorders, with significant contributions to understanding venous thrombosis mechanisms, factor VIII therapies for hemophilia A, and the role of various proteins in blood clotting processes. Her work bridges basic science with clinical applications, particularly in non-malignant blood disorders. Dr. Aleman maintains an active research laboratory (the Aleman Lab) at UNC Chapel Hill, where she investigates the basic mechanisms regulating erythropoiesis. Her work combines expertise in pharmacology, hematology, and molecular biology to address fundamental questions about blood cell formation and function. While specific grant information isn't detailed in the available materials, her consistent publication record across multiple high-impact journals suggests sustained research funding in her areas of expertise.

Jennifer Perry Cecileمشاهده پروفایل

دانشیار

• Biochemistry
• Biophysical Chemistry
• Molecular Biology
• +۶ مورد دیگر

Dr. Jennifer Perry Cecile is an Associate Professor and Department Chair at Appalachian State University in the Department of Chemistry and Fermentation Sciences. She is a research mentor with a focus on biochemistry, biophysical chemistry, and molecular biology. Ph.D. in Biophysical Chemistry from Duke University Her research explores organic anion transporters (OATs) , including their structure/function relationships, genetic variability, and regulation. She utilizes techniques from biochemistry and molecular biology, with a notable emphasis on Caenorhabditis elegans as a model system and computational modeling of transporter proteins. Recent publications highlight her work on xenobiotic transport, Moringa oleifera's antimicrobial properties, biofilm formation in Vibrio cholerae, and the role of lipid rafts in OAT3 regulation. Her studies span from 2001 to 2020, focusing on pharmacology, toxicology, and protein structure.

Philip Bittihnمشاهده پروفایل

پژوهشگر ارشد

• Nonlinear Dynamics
• Biological Physics
• Active Matter
• +۶ مورد دیگر

Dr. Philip Bittihn serves as Group Leader and Scientist at the Max Planck Institute for Dynamics and Self-Organization in Göttingen, Germany, heading the Emergent Dynamics in Living Systems research group within the Department of Living Matter Physics. His work bridges physics and biology to decipher complex emergent behaviors in biological systems through innovative interdisciplinary approaches. His research spans nonlinear dynamics in biological systems , initially focusing on cardiac arrhythmia mechanisms where he identified novel termination strategies for life-threatening rhythms through topological defect analysis. Current work centers on growth-driven phenomena in cellular active matter , investigating mechanical interactions, expansion flows, orientational order, and shape development coupled with gene regulation and metabolism. He employs reaction-diffusion modeling, synthetic biology, and microfluidic experimentation to study pattern formation in microbial colonies and cardiac tissue. Analysis of recent publications reveals a dominant trend toward active matter physics in multicellular systems , particularly geometry-induced nematic order, phase separation in proliferating matter, and nutrient-mediated antibiotic responses. His group consistently explores how non-equilibrium growth processes generate complex patterns, with increasing emphasis on mechanical stress anisotropy and motility-induced transitions in confined cellular environments. The Emergent Dynamics in Living Systems group operates at the physics-biology interface, utilizing genetically engineered E. coli models (as demonstrated in their Nature Microbiology 2020 work on oscillating growth patterns), advanced microfluidic chambers, and computational frameworks to investigate fundamental principles of biological organization with potential biomedical applications.

• Sleep Medicine
• Respiratory Disorders
• Critical Care Medicine
• +۳ مورد دیگر

Dr. Robert Skomro , a Physician Scientist at the University of Saskatchewan's College of Medicine , is a leading figure in sleep and respiratory medicine. As Division Head of Respirology, Critical Care & Sleep Medicine, he spearheaded global guidelines for sleep-disordered breathing diagnosis and treatment. Clinical and research leadership in sleep medicine Focus on obstructive sleep apnea (OSA), biomarkers, and cognitive impacts Key role in advancing respiratory research infrastructure in Saskatchewan Dr. Skomro's recent work explores OSA-related hypoxemia, neurophysiological responses, and systemic inflammation, with a strong emphasis on Indigenous communities' sleep health. His research bridges clinical practice and translational science, including novel imaging techniques for pulmonary fibrosis. He chairs the Canadian Thoracic Society Sleep and Breathing Committee and co-founded the Respiratory Research Centre (RRC) , fostering interdisciplinary clusters in cystic fibrosis and interstitial lung disease. His vision emphasizes collaboration across medicine, science, and global talent to address future challenges in respiratory care.

Caius Raduمشاهده پروفایل

استاد

• Cancer metabolism
• Nucleotide metabolism
• Molecular imaging
• +۴ مورد دیگر

Caius Radu, M.D., is a full Professor in the Departments of Molecular and Medical Pharmacology and Surgery at the University of California, Los Angeles (UCLA). He also serves as Vice-Chairman of the Department of Molecular and Medical Pharmacology and as Co-Director of the Cancer Molecular Imaging, Nanotechnology, and Theranostics Research Program (CMINT) within the Jonsson Comprehensive Cancer Center. Education: M.D., University of Medicine, Craiova, Romania Postdoctoral training in immunology and cancer biology, University of Texas Southwestern Medical Center (Dallas) Postdoctoral training at UCLA under the mentorship of Dr. Owen Witte Research Interests: Dr. Radu's laboratory investigates the intersection of metabolic signaling , nucleotide metabolism , and immune networks in cancer, with a translational focus on molecular imaging and theranostic applications. Key efforts include elucidating novel mechanisms regulating nucleotide metabolism in pancreatic and prostate cancers, identifying actionable co-dependencies, and developing non-invasive imaging probes that predict therapeutic response. The group integrates rigorous pre-clinical mouse models with cutting-edge PET imaging to accelerate bench-to-bedside translation. Current projects revolve around STING pathway activation , PSMA-targeted radioligand therapy , CD73 adenosine blockade , mutant KRAS inhibition , and mRNA cancer vaccines . These multi-pronged strategies aim to overcome tumor immune evasion, enhance cytotoxic therapies, and personalize treatment selection. Recent Publication Trends: From 2020-2025, the Radu group has published extensively on synergistic combination therapies that pair immune checkpoint modulation with targeted metabolic inhibition. A dominant theme is leveraging nucleoside analog PET tracers (e.g., 18F-FAC, 18F-CFA) to visualize immune activation and metabolic stress in real time. Parallel studies dissect resistance mechanisms to PSMA-targeted alpha therapy and explore STING agonism as a strategy to sensitize otherwise refractory pancreatic and prostate tumors. Scientific Awards & Honors: While the provided text does not enumerate specific awards, Dr. Radu’s leadership roles at UCLA and the Jonsson Comprehensive Cancer Center, along with continuous high-impact publications, attest to sustained recognition in cancer research. Advising & Team: Dr. Radu mentors an active bench-to-bedside team comprising: Graduate Students: Amanda Creech, Hailey Lee Postdoctoral Scholar: Khalid Rashid Staff Research Associate: Weihang Zhao Lab Manager: Nanping Wu Laboratory & Core Affiliations: The Radu laboratory operates within the CMINT program at the Jonsson Comprehensive Cancer Center, with ready access to UCLA’s preclinical imaging cores, flow cytometry facilities, and translational pathology resources. Collaborative ties span the departments of Molecular and Medical Pharmacology, Surgery, Radiological Sciences, and the Institute for Molecular Medicine.

Edward Kellyمشاهده پروفایل

عضو هیئت علمی

• Toxicology
• Biotechnology
• Drug Metabolism
• +۴ مورد دیگر

Edward Kelly is a Professor and Adjunct Professor at the University of Washington , affiliated with the School of Pharmacy and the Department of Pharmaceutics , as well as the Environmental & Occupational Health Sciences . He is the Co-Director of the Pharmaceutical Bioengineering Program and leads the Kelly Lab , which focuses on microphysiological systems (organs-on-chips) for preclinical toxicology and drug metabolism research. Education : BS, MS, and PhD in Biochemistry from UC Riverside and the University of Washington. His research interests center on ex vivo modeling of human organ physiology and toxicological responses to drugs and xenobiotics, with a focus on liver and kidney ADME organs . His lab is pioneering the use of organs-on-chips to replace animal testing (the 3 Rs) and study disease models and microgravity effects on the International Space Station. His publications highlight the application of microphysiological systems in nephrotoxicity , drug metabolism , and multi-organ coupling . Key themes include toxicology , translational research , and biomedical engineering for preclinical models . Edward Kelly teaches courses such as Biotechnology and Biopharmaceuticals , Drug Disposition Science , and Pharmacokinetics . His lab actively accepts students , and he collaborates with institutions like the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute and the Program on Pharmacokinetics of Drugs of Abuse during Pregnancy (UWPKDAP) .

Craig C. Malbonمشاهده پروفایل

استاد

• Signal Transduction
• Molecular Scaffold Biology
• Wnt Signaling Pathways
• +۶ مورد دیگر

Craig C. Malbon is a Leading Professor at Stony Brook University's School of Medicine, holding primary appointments in the Department of Pharmacological Sciences and secondary affiliation with the Department of Family, Population & Preventive Medicine. He directs an active research laboratory established in 1978 and serves as Director-emeritus of the NIH-funded Diabetes & Metabolic Diseases Research Program (1986-2015). Ph.D. in Pharmacology from Case Western Reserve University Postdoctoral training at Brown University and Harvard University M.Div. in Ethics from Union Theological Seminary Visiting Scholar at Princeton Theological Seminary His research focuses on signal transduction mechanisms in development and disease, specializing in molecular scaffold proteins (Dishevelleds and AKAPs) that organize signaling complexes. His laboratory employs advanced techniques including fluorescence correlation spectroscopy, proteomics, and live-cell imaging to study Wnt signaling and GPCR regulation. His 290+ publications reveal consistent emphasis on spatiotemporal aspects of cellular signaling with applications to cancer, metabolic disorders, and developmental biology. Recent work increasingly integrates his dual expertise through investigations into consciousness, moral formation, and bioethics failures . Recipient of the American Cancer Society Research Award (1997) Top 10 Researchers recognition (1990-2000) Goodman & Gilman Award from ASPET (2008) Fellow of AAAS (2008) Overseas Fellow, Royal Society of Medicine (2015) As an ethicist and ordained United Church of Christ minister, he directs bioethics training within NIH postdoctoral programs and has authored three books: Abortion in 21st Century America (2013), Assaulted Personhood (2021), and GUN-AMERICA (2022). His laboratory has trained over 75 doctoral students and 100 NIH fellows through the NIDDK-funded program, with alumni pursuing careers in academia, industry, and clinical research.

Allen Fengمشاهده پروفایل

پژوهشگر ارشد

• Developmental Biology
• Reproductive Biology
• Molecular Biology
• +۳ مورد دیگر

Dr Allen Feng is a postdoctoral research fellow at the School of Biomedical Sciences , The University of Queensland. He is affiliated with the Bowles group , specializing in developmental reproductive biology. His research focuses on germ cell regulation, gonadal development, and signaling pathways in mammalian and avian models. Bachelor of Science (The University of Queensland) Bachelor (Honours) of Science (Advanced) (The University of Queensland) Doctor of Philosophy (The University of Queensland, 2016) Allen's research spans Developmental Biology , Genetics , and Molecular Biology , with key contributions to understanding meiosis regulation, retinoic acid signaling, and transcriptional control in germ cell development. His work includes studies on SOX30's role in male fertility and STRA8 expression in ovarian germ cells. Recent articles highlight his expertise in germ cell fate determination , retinoic acid metabolism , and transgenic models for developmental studies. He has contributed to virology through plant virus diagnostics but primarily focuses on biomedical sciences. Scientific awards include the Ian Potter Foundation Travel Grant (2017) for SOX30 research. Allen is available for supervision and collaborates with teams exploring gonadal development and reproductive health.

Daniel J Bratمشاهده پروفایل

استاد

• Neuropathology
• Glioblastoma Research
• Cancer Biology
• +۸ مورد دیگر

Daniel J Brat serves as Chair of the Department of Pathology and holds the Magerstadt Professorship at Northwestern University's Feinberg School of Medicine. He maintains dual professorial appointments in Pathology (Experimental Pathology) and Pathology (Neuropathology), leading significant research initiatives at the Robert H. Lurie Comprehensive Cancer Center. Dr. Brat's research focuses on the biological mechanisms underlying glioma progression, particularly glioblastoma (GBM). His laboratory investigates genetics, hypoxia, tumor microenvironment dynamics, and glioma stem cell behavior. Key research areas include asymmetric cell division regulation, hypoxia-induced microvascular hyperplasia, and the role of vaso-occlusion in tumor necrosis. His team employs patient-derived samples, mouse models, and Drosophila systems to elucidate fundamental cancer biology principles. Analysis of Dr. Brat's publication record reveals consistent research themes spanning molecular mechanisms of glioblastoma progression, with particular emphasis on tumor microenvironment interactions, stem cell regulation, and translational applications. His work demonstrates strong integration of basic science with clinical pathology, leveraging large datasets like TCGA while maintaining experimental validation through sophisticated in vivo models including intravital microscopy. Dr. Brat leads multiple clinical trials focused on pathology specimen collection and analysis, serving as principal investigator for the Pathology Core Facility and Breast Cancer Program tissue collection initiatives. His laboratory currently mentors a diverse team including graduate students, postdoctoral scholars, medical students, and undergraduates, with numerous former trainees now established in academic and clinical pathology positions. The Brat Lab, located in the Montgomery Ward Building at Northwestern's Chicago campus, maintains active research programs in glioblastoma progression mechanisms, asymmetric cell division in glioma stem cells, and in silico brain tumor research. The lab collaborates extensively with the Simpson Querrey Center for Neurogenetics, Simpson Querrey Institute for Epigenetics, and Center for Human Immunobiology, reflecting the interdisciplinary nature of modern cancer research.

Mark Albersمشاهده پروفایل

استادیار

• Alzheimer's Disease
• Amyotrophic Lateral Sclerosis (ALS)
• Olfactory Disorders
• +۹ مورد دیگر

Mark Albers is an Assistant Professor of Neurology at Harvard Medical School and a clinician-investigator at Massachusetts General Hospital (MGH), where he directs the Albers Laboratory at the MassGeneral Institute for Neurodegenerative Disease (MIND). His research bridges clinical and basic science, focusing on early detection and therapeutic development for neurodegenerative diseases like Alzheimer’s, ALS, Parkinson’s, and traumatic brain injury through olfactory system studies. Education: PhD in Organic Chemistry from Harvard Graduate School of Arts and Sciences (1995), MD from Harvard Medical School (1995). Clinical Expertise: Memory and olfactory disorders; practices in the Memory Disorders Unit at MGH. His lab investigates pathogenic mechanisms of neurodegenerative disease genes using transgenic mouse models, CRISPR screens, multiphoton imaging, and in silico drug trials. Key projects include identifying olfactory deficits as early biomarkers and repurposing FDA-approved drugs for neurodegenerative diseases via the NADALS basket trial. Publications span Alzheimer’s disease , olfactory dysfunction , neuroinflammation , systems pharmacology , and CRISPR technology . Collaborations with the Laboratory of Systems Pharmacology and Harvard Program in Therapeutic Science further his translational goals.

Mandana Arbabمشاهده پروفایل

استادیار

• Genome Editing
• Neurodegenerative Diseases
• Genetic Disorders
• +۳ مورد دیگر

Mandana Arbab is an Assistant Professor of Neurology at Harvard Medical School and leads the Arbab Lab at the Translational Neuroscience Center of Boston Children’s Hospital. Her research focuses on advancing genome editing platforms to study and treat neurodegenerative diseases , including spinal muscular atrophy (SMA), Huntington’s disease, and Friedreich’s ataxia. Research Interests Dr. Arbab’s work centers on developing precise CRISPR-based technologies , such as base editing and prime editing , to correct disease-causing mutations or modulate genomic activity. Her lab employs machine learning to optimize editing outcomes and explores therapeutic strategies in cellular and murine models. Publications Summary Recent studies highlight her innovations in C•G-to-G•C base editing , predictive algorithms for edit outcomes, and cloning-free CRISPR methodologies. Her work bridges genomic engineering and neurology , aiming to translate these tools into clinical applications. Labs & Collaborations The Arbab Lab, based at Boston Children’s Hospital, fosters a diverse and collaborative environment. With a team of 5-10 members, they partner with institutions to develop gene-based therapeutics and investigate cellular mechanisms of neurodegeneration . Contact: mandana.arbab@childrens.harvard.edu | arbablab.com